Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 4.42M | $1.64B | 14.93% | +44.2K | 2026-06-30 |
| BlackRock, Inc. | 4.18M | $1.55B | 14.13% | +241.0K | 2026-06-30 |
| Avoro Capital Advisors LLC | 2.89M | $1.07B | 9.76% | -- | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.57M | $585.0M | 5.32% | +118.2K | 2026-06-30 |
| STATE STREET CORP | 1.35M | $502.0M | 4.57% | +36.7K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.24M | $461.0M | 4.19% | +75.2K | 2026-06-30 |
| Soleus Capital Management, L.P. | 939.3K | $349.0M | 3.17% | -213.8K | 2026-06-30 |
| Capital World Investors | 777.8K | $289.0M | 2.63% | -46.9K | 2026-06-30 |
| VESTOR CAPITAL, LLC | 700.9K | $78.0M | 2.37% | +700.7K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 699.0K | $259.0M | 2.36% | +55.0K | 2026-06-30 |
